Wealthstream Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,319
Closed -$208K 189
2025
Q1
$208K Buy
2,319
+86
+4% +$8.03K 0.04% 144
2024
Q4
$222K Sell
2,233
-205
-8% -$21.1K 0.04% 140
2024
Q3
$277K Sell
2,438
-122
-5% -$14.5K 0.05% 118
2024
Q2
$317K Buy
2,560
+87
+4% +$11.2K 0.12% 91
2024
Q1
$326K Sell
2,473
-1,505
-38% -$186K 0.12% 92
2023
Q4
$434K Buy
3,978
+1,568
+65% +$163K 0.18% 80
2023
Q3
$248K Sell
2,410
-32
-1% -$3.45K 0.13% 91
2023
Q2
$282K Buy
+2,442
New +$277K 0.15% 75

Other funds holding MRK

Wealthstream Advisors's MRK Position: Q2 2025 in Review

Wealthstream Advisors sold out of Merck (MRK) in Q2 2025, closing a stake of 2,319 shares — an estimated $208K sold.

Wealthstream Advisors first reported a position in MRK in Q2 2023 and held it in 8 quarters. The position peaked at $434K in Q4 2023. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Wealthstream Advisors reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • Wealthstream Advisors sold 2,319 Merck shares in Q2 2025, an estimated $208K.
  • Wealthstream Advisors first reported a position in Merck in Q2 2023 and held it in 8 quarters.
  • Wealthstream Advisors's Merck position peaked at $434K in Q4 2023.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Wealthstream Advisors's 13F filing for Q2 2025, filed 29 Jul 2025.